Details
- Close date
- No date set
- Academic background
- Health Sciences
- Host campus
- Dunedin
- Qualification
- Postgraduate Diploma, Master's, Honours
- Department
- Pathology (Dunedin)
- Supervisor
- Dr Cath Drummond, Dr Glen Reid
Overview
Cancer treatment has been revolutionised by therapies which act by specifically blocking the pathways that drive cancer.
However, despite initial dramatic results, relapse is inevitable and a major clinical problem.
Recent studies have identified a rare population of drug-tolerant cells as being largely responsible for relapse. These cells evade therapy by changing their identity during the course of treatment, thus surviving to repopulate the tumour.
This project involves using cellular and molecular biology to understand how drug-tolerant cells evade therapy to survive treatment.
Useful information
Similar research opportunities
- A phoenix from the ashes: Do dying cancer cells induce drug-tolerance in lung cancer?
- A role for untranslated p53 mRNA in drug resistance
- Characterisation of YB-1 interactions with the cytoskeleton using live cell imaging
- Characteristion of YB-1 interactions with the cytoskeleton using live cell imaging
- Comprehensive characterization of uncommon TP53 mutations in cancer